Need a specific person's email?
Browse Alcyone Therapeutics Inc.'s employee directory (about 8 employees) and reveal verified emails free.
Alcyone Therapeutics Inc.'s most common email format is FLast@alcyonetx.com (ex. JDoe@alcyonetx.com), used for 80% of alcyonetx.com addresses. Alcyone Therapeutics Inc. uses 7 email patterns across 2 domains: alcyonetx.com and alcyonels.com. Percentages are the share of addresses within each domain.
| Format | Example | Share of alcyonetx.com |
|---|---|---|
| FLast@alcyonetx.comMost common | JDoe@alcyonetx.com | |
| Last@alcyonetx.com | Doe@alcyonetx.com | |
| FirstLast@alcyonetx.com | JohnDoe@alcyonetx.com |
| Format | Example | Share of alcyonels.com |
|---|---|---|
| FLast@alcyonels.comMost common | JDoe@alcyonels.com | |
| FirstLast@alcyonels.com | JohnDoe@alcyonels.com | |
| FMLast@alcyonels.com | JMDoe@alcyonels.com | |
| First.Last@alcyonels.com | John.Doe@alcyonels.com |
Browse Alcyone Therapeutics Inc.'s employee directory (about 8 employees) and reveal verified emails free.
Biotechnology ResearchMassachusetts, United States2-10 Employees
Alcyone Therapeutics Inc. is a small biotechnology research company based in Lowell, Massachusetts, focused on precision genetic therapies for neurological conditions. It operates at the clinical stage and aims to improve delivery of antisense oligonucleotide therapies for CNS targets. The company has been developing ThecaFlex DRx since 2019 and manufactures the product locally in Lowell. Its work has involved collaboration with Biogen, reflecting a close industry partnership. In 2025, Alcyone Therapeutics was acquired by Biogen, and the company page notes it is no longer updated. Recent reporting indicates that ThecaFlex DRx received FDA Breakthrough Device Designation, highlighting progress in device-enabled delivery of genetic therapies.
Most common format
FLast@alcyonetx.com
Example: JDoe@alcyonetx.com
Free with a LeadIQ account. No credit card.
Get a demo and discover why thousands of SDR and Sales teams trust LeadIQ to help them build pipeline confidently.